Cite

HARVARD Citation

    Wang, C. et al. (2022). The anti-fibrotic agent nintedanib protects chondrocytes against tumor necrosis factor-ɑ (TNF-ɑ)-induced extracellular matrix degradation. Bioengineered. 13 (3), pp. 5318-5329. [Online]. 
  
Back to record